NPRA published Guidance Document and Guidelines for Registration of Biosimilars in Malaysia

The NPRA has released a revised edition of the biosimilar product registration guidelines in the second edition of the Guidance Document and Guidelines for Registration of Biosimilars in Malaysia (December 2023).

Aligned with the 2022 WHO biosimilar guideline, the key changes offer enhanced clarity on…